UnitedHealth Group Incorporated $UNH Shares Acquired by Prime Capital Investment Advisors LLC

Prime Capital Investment Advisors LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 25,076 shares of the healthcare conglomerate’s stock after buying an additional 1,303 shares during the period. Prime Capital Investment Advisors LLC’s holdings in UnitedHealth Group were worth $9,205,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. LFG Wealth Partners LLC raised its holdings in UnitedHealth Group by 3.3% in the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock valued at $355,000 after acquiring an additional 27 shares during the last quarter. Synergy Financial Group LTD lifted its stake in shares of UnitedHealth Group by 3.1% during the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after purchasing an additional 27 shares during the period. Ares Financial Consulting LLC boosted its holdings in shares of UnitedHealth Group by 7.2% during the second quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after purchasing an additional 28 shares during the last quarter. Hudock Inc. grew its position in shares of UnitedHealth Group by 1.0% in the second quarter. Hudock Inc. now owns 2,844 shares of the healthcare conglomerate’s stock valued at $1,182,000 after purchasing an additional 28 shares during the period. Finally, Onyx Bridge Wealth Group LLC grew its position in shares of UnitedHealth Group by 4.3% in the third quarter. Onyx Bridge Wealth Group LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $249,000 after purchasing an additional 28 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on UNH shares. The Goldman Sachs Group increased their target price on UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Wall Street Zen upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. DA Davidson set a $512.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, July 21st. New Street Research set a $402.00 price objective on shares of UnitedHealth Group in a report on Friday, October 9th. Finally, Sanford C. Bernstein decreased their target price on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $463.57.

UnitedHealth Group Trading Up 3.2%

UNH stock opened at $419.70 on Wednesday. The company has a market cap of $376.72 billion, a price-to-earnings ratio of 23.97, a PEG ratio of 1.47 and a beta of 0.60. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The business has a fifty day simple moving average of $387.40 and a 200-day simple moving average of $387.49. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same period last year, the company posted $2.59 EPS. The business’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 20.64 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.19% of the stock is owned by corporate insiders.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: A Seeking Alpha analyst initiated coverage with a Strong Buy rating and a $533 price target, citing margin recovery, improved Optum Health contracts and AI-related efficiencies as potential drivers of double-digit EPS growth through 2028. The analyst also viewed UNH’s valuation as discounted relative to the healthcare sector. UnitedHealth: Optum’s Recovery Supports My Strong Buy Rating
• Positive Sentiment: UnitedHealth was selected as a CNBC “Final Trades” stock after its better-than-expected quarterly results, adding to favorable short-term investor sentiment. Twilio, Transocean and a Health Care Stock on CNBC’s Final Trades
• Positive Sentiment: Analysts and investors are reassessing UNH after the earnings beat and raised outlook, while commentary suggests the stock’s recent momentum reflects renewed confidence in medical-cost trends and operational execution. UnitedHealth Group Has The Market Asking A Bigger Question
• Neutral Sentiment: UnitedHealth’s results have renewed interest in healthcare ETFs with UNH exposure, although diversification may reduce the impact of company-specific gains and limit direct upside. Healthcare ETFs to Buy as UnitedHealth Beats on Q3 Earnings
• Negative Sentiment: A competing analyst downgraded UNH from Strong Buy to Buy, arguing that the shares may already reflect much of the recovery at roughly 20 times forward earnings. Valuation, medical-cost pressure and execution risks remain concerns. UnitedHealth: My Thesis Has Played Out, I Wouldn’t Chase Here
• Negative Sentiment: Reports of rising healthcare costs, reduced services and higher prescription-drug prices for older Americans could increase political scrutiny and pressure insurers’ affordability and retention metrics. Older Americans Brace for Higher Healthcare Costs Ahead of Midterms
• Negative Sentiment: Declining individual-market enrollment and reports that millions of seniors may lose Medicare Advantage plans highlight regulatory, membership and pricing risks for the broader insurance industry, including UNH. 3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.